Your browser doesn't support javascript.
loading
Novel therapeutic mechanism of action of metformin and its nanoformulation in Alzheimer's disease and role of AKT/ERK/GSK pathway.
Kumar, Harish; Chakrabarti, Amitava; Sarma, Phulen; Modi, Manish; Banerjee, Dibyajyoti; Radotra, B D; Bhatia, Alka; Medhi, Bikash.
Afiliação
  • Kumar H; Department of Pharmacology, PGIMER, Chandigarh.
  • Chakrabarti A; Department of Pharmacology, PGIMER, Chandigarh.
  • Sarma P; Department of Pharmacology, PGIMER, Chandigarh.
  • Modi M; Department of Neurology, PGIMER, Chandigarh.
  • Banerjee D; Department of Experimental Medicine & Biotechnology, PGIMER, Chandigarh. Electronic address: dibyajyoti5200@yahoo.co.in.
  • Radotra BD; Department of Histopathology, PGIMER, Chandigarh.
  • Bhatia A; Department of Experimental Medicine & Biotechnology, PGIMER, Chandigarh. Electronic address: alkabhatia@ymail.com.
  • Medhi B; Department of Pharmacology, PGIMER, Chandigarh. Electronic address: drbikashus@yahoo.com.
Eur J Pharm Sci ; 181: 106348, 2023 Feb 01.
Article em En | MEDLINE | ID: mdl-36496166

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Eur J Pharm Sci Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Eur J Pharm Sci Ano de publicação: 2023 Tipo de documento: Article